Electrophysiological, Pharmacological, and Molecular Evidence for α7-Nicotinic Acetylcholine Receptors in Rat Midbrain Dopamine Neurons

  1. Jie Wu,
  2. Andrew A. George,
  3. Katherine M. Schroeder,
  4. Lin Xu,
  5. Syndia Marxer-Miller,
  6. Linda Lucero and
  7. Ronald J. Lukas
  1. Divisions of Neurology (J.W.) and Neurobiology (A.A.G., K.M.S., L.X., S.M.-M., L.L., R.J.L.), Barrow Neurological Institute, Phoenix, Arizona
  1. Address correspondence to:
    Dr. Jie Wu, Division of Neurology, Barrow Neurological Institute, 350 West Thomas Road, Phoenix, AZ 85013-4496. E-mail: jwu2{at}chw.edu

Abstract

Dopamine (DA) neurons located in the mammalian midbrain have been generally implicated in reward and drug reinforcement and more specifically in nicotine dependence. However, roles played by nicotinic acetylcholine receptors, including those composed of α7-subunits [α7-nicotinic acetylcholine receptors (nAChRs)], in modulation of DA signaling and in nicotine dependence are not clearly understood. Although midbrain slice recording has been used previously to identify functional α7-nAChRs, these preparations are not optimally designed for extremely rapid and reproducible drug application, and rapidly desensitized, α7-nAChR-mediated currents may have been underestimated or not detected. Here, we use patch-clamp, whole-cell current recordings from single neurons acutely dissociated from midbrain nuclei and having features of DA neurons to characterize acetylcholine-induced, inward currents that rapidly activate and desensitize, are mimicked by the α7-nAChR-selective agonist, choline, blocked by the α7-nAChR-selective antagonists, methyllycaconitine and α-bungarotoxin, and are similar to those of heterologously expressed, human α7-nAChRs. We also use reverse transcriptase-polymerase chain reaction, in situ hybridization, and immunocytochemical staining to demonstrate nAChR α7 subunit gene expression as message and protein in the rat substantia nigra pars compacta and ventral tegmental area. Expression of α7 subunit message and of α7-nAChR-mediated responses is developmentally regulated, with both being absent in samples taken from rats at postnatal day 7, but later becoming present and increasing over the next 2 weeks. Collectively, this electrophysiological, pharmacological, and molecular evidence indicates that nAChR α7 subunits and functional α7-nAChRs are expressed somatodendritically by midbrain DA neurons, where they may play important physiological roles and contribute to nicotine reinforcement and dependence.

Footnotes

  • This study was supported by the National Institutes of Health (Grant NS040417), the Arizona Disease Control Research Commission (Grants 5007 and 5011), the Robert and Gloria Wallace Foundation, and the Marjorie Newsome and Sandra Solheim Aiken funds and was conducted in part at the Charlotte and Harold Simensky Neurochemistry of Alzheimer's Disease Laboratory. The contents of this report are solely the responsibility of the authors and do not necessarily represent the views of the aforementioned awarding agencies.

  • doi:10.1124/jpet.104.070417.

  • ABBREVIATIONS: DA, dopamine or dopaminergic; VTA, ventral tegmental area; SNc, substantia nigra pars compacta; nAChR, nicotinic acetylcholine receptor(s); Bgt, α-bungarotoxin; ACh, acetylcholine; MLA, methyllycaconitine; PBS, phosphate-buffered saline; ddH2O, double distilled H2O; PCR, polymerase chain reaction; SSC, standard saline citrate; RT, reverse transcriptase; IACh, current response induced by acetylcholine; CNQX, 6-cyano-2,3-dihydroxy-7-nitroquinoxaline; APV, 2-amino-5-phosphonovalerate; Icholine, current response induced by choline.

    • Received April 21, 2004.
    • Accepted June 2, 2004.
« Previous | Next Article »Table of Contents